Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association

H Kong, K Raynor, K Yasuda, GI Bell and T Reisine

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.

Sodium ions have been shown to reduce the binding of agonists to a number of G protein-linked receptors. They are believed to do so by interacting with aspartate residues in the second membrane-spanning region of these receptors to cause G protein uncoupling, resulting in a diminished affinity of the receptors for agonists. To investigate Na+ regulation of agonist binding to somatostatin receptors, Na+ was tested for its effect on the binding of agonists to cloned somatostatin receptor type 1 (SSTR1) and somatostatin receptor type 2 (SSTR2) stably expressed in Chinese hamster ovary cells. Na+ reduced agonist binding to SSTR2 but not to SSTR1. Because high affinity agonist binding to SSTR1 does not depend on G protein coupling but agonist binding to SSTR2 is reduced by guanosine-5'-(beta, gamma-imido)triphosphate and pertussis toxin treatment, the selective Na+ effect on SSTR2 is consistent with previous findings with other receptors showing that Na+ uncouples receptors from G proteins, thereby reducing the affinity of the receptors for agonists. Conversion of Asp89 to Asn89 in SSTR2 resulted in a mutant receptor whose affinity for agonists was not altered by Na+, indicating that Asp89 is involved in mediating the effects of Na+ on agonist binding to SSTR2. However, the affinities of the mutant and wild-type receptors for somatostatin were the same, and both guanosine-5'-O-(gamma-thio)triphosphate and pertussis toxin treatment reduced agonist binding to the mutant and wild-type receptors. These findings differ from the results of similar mutagenesis studies on other G protein-linked receptors, in that the mutant and wild-type SSTR2 forms associate with G proteins in similar ways. These results indicate that Asp89 acts in a novel manner to regulate agonist binding and G protein interaction with SSTR2.

Volume 44, Issue 2, pp. 380-384, 08/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J H Li, F Sicard, M A Salam, M Baek, J LePrince, H Vaudry, K Kim, H B Kwon, and J Y Seong Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain J. Mol. Endocrinol., June 1, 2005; 34(3): 793 - 807. [Abstract] [Full Text] [PDF]

				R. Seifert Monovalent Anions Differentially Modulate Coupling of the beta 2-Adrenoceptor to Gsalpha Splice Variants J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 840 - 847. [Abstract] [Full Text] [PDF]

				J. A. Durr, J. Hensen, T. Ehnis, and M. S. Blankenship Chlorpropamide upregulates antidiuretic hormone receptors and unmasks constitutive receptor signaling Am J Physiol Renal Physiol, May 1, 2000; 278(5): F799 - F808. [Abstract] [Full Text] [PDF]

				J. P. Roche, S. Bounds, S. Brown, and K. Mackie A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization Mol. Pharmacol., September 1, 1999; 56(3): 611 - 618. [Abstract] [Full Text]

				S. Martin, J.-M. Botto, J.-P. Vincent, and J. Mazella Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors Mol. Pharmacol., February 1, 1999; 55(2): 210 - 215. [Abstract] [Full Text]

				J. Marie, C. Koch, D. Pruneau, J.-L. Paquet, T. Groblewski, R. Larguier, C. Lombard, B. Deslauriers, B. Maigret, and J.-C. Bonnafous Constitutive Activation of the Human Bradykinin B2 Receptor Induced by Mutations in Transmembrane Helices III and VI Mol. Pharmacol., January 1, 1999; 55(1): 92 - 101. [Abstract] [Full Text]

				K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]

				Q. Tao and M. E. Abood Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 651 - 658. [Abstract] [Full Text]

				H. Sadeghi, G. L. Robertson, D. G. Bichet, G. Innamorati, and M. Birnbaumer Biochemical Basis of Partial Nephrogenic Diabetes Insipidus Phenotypes Mol. Endocrinol., November 1, 1997; 11(12): 1806 - 1813. [Abstract] [Full Text]

				A. J. Williams, A. D. Michel, W. Feniuk, and P. P. A. Humphrey Somatostatin5 Receptor-Mediated [35S]Guanosine-5'-O-(3-thio)triphosphate Binding: Agonist Potencies and the Influence of Sodium Chloride on Intrinsic Activity Mol. Pharmacol., June 1, 1997; 51(6): 1060 - 1069. [Abstract] [Full Text]

				J. Mazella, J.-M. Botto, E. Guillemare, T. Coppola, P. Sarret, and J.-P. Vincent Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain J. Neurosci., September 15, 1996; 16(18): 5613 - 5620. [Abstract] [Full Text] [PDF]

				S. C. Sealfon, L. Chi, B. J. Ebersole, V. Rodic, D. Zhang, J. A. Ballesteros, and H. Weinstein Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT[IMAGE] Receptor J. Biol. Chem., July 14, 1995; 270(28): 16683 - 16688. [Abstract] [Full Text] [PDF]